Biofarm S.A. (BVB:BIO)
0.836
+0.006 (0.72%)
At close: Dec 5, 2025
Biofarm Income Statement
Financials in millions RON. Fiscal year is January - December.
Millions RON. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 318.89 | 286.77 | 280.29 | 276.98 | 239.04 | 216.42 | Upgrade
|
| Revenue | 318.89 | 286.77 | 280.29 | 276.98 | 239.04 | 216.42 | Upgrade
|
| Revenue Growth (YoY) | 12.93% | 2.31% | 1.19% | 15.87% | 10.45% | 10.80% | Upgrade
|
| Cost of Revenue | 50.9 | 47.15 | 49.98 | 45.69 | 40.44 | 39.64 | Upgrade
|
| Gross Profit | 267.99 | 239.62 | 230.31 | 231.29 | 198.6 | 176.78 | Upgrade
|
| Selling, General & Admin | 118.28 | 108.6 | 109.68 | 105.69 | 90.13 | 82.01 | Upgrade
|
| Amortization of Goodwill & Intangibles | - | - | - | - | 13.32 | 11.12 | Upgrade
|
| Other Operating Expenses | 38.64 | 35.9 | 28.86 | 33.14 | 26.29 | 19.98 | Upgrade
|
| Operating Expenses | 174.15 | 161.39 | 153.06 | 154.18 | 129.74 | 113.12 | Upgrade
|
| Operating Income | 93.84 | 78.23 | 77.25 | 77.11 | 68.87 | 63.67 | Upgrade
|
| Interest Expense | - | - | -0 | -0 | -0 | -0 | Upgrade
|
| Interest & Investment Income | 7.97 | 6.41 | 6.88 | 3.14 | 0.88 | 1.18 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.78 | - | -0.16 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | 101.04 | 84.64 | 83.97 | 80.25 | 69.74 | 64.85 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0 | -0 | -0.01 | - | -0.19 | - | Upgrade
|
| Asset Writedown | - | - | - | 1.84 | - | - | Upgrade
|
| Legal Settlements | -0.14 | -0.11 | -0.25 | -1.21 | - | - | Upgrade
|
| Pretax Income | 100.89 | 84.53 | 83.71 | 80.88 | 69.55 | 64.85 | Upgrade
|
| Income Tax Expense | 12.68 | 10.13 | 6.7 | 9.96 | 9.2 | 10.58 | Upgrade
|
| Net Income | 88.21 | 74.4 | 77.01 | 70.92 | 60.36 | 54.26 | Upgrade
|
| Net Income to Common | 88.21 | 74.4 | 77.01 | 70.92 | 60.36 | 54.26 | Upgrade
|
| Net Income Growth | 9.82% | -3.40% | 8.60% | 17.50% | 11.22% | 6.65% | Upgrade
|
| Shares Outstanding (Basic) | 985 | 985 | 985 | 985 | 985 | 985 | Upgrade
|
| Shares Outstanding (Diluted) | 1,085 | 1,085 | 1,080 | 1,071 | 1,061 | 1,057 | Upgrade
|
| Shares Change (YoY) | 0.40% | 0.40% | 0.83% | 1.01% | 0.34% | 0.17% | Upgrade
|
| EPS (Basic) | 0.09 | 0.08 | 0.08 | 0.07 | 0.06 | 0.06 | Upgrade
|
| EPS (Diluted) | 0.08 | 0.07 | 0.07 | 0.07 | 0.06 | 0.05 | Upgrade
|
| EPS Growth | 9.38% | -3.79% | 7.70% | 16.35% | 10.92% | 6.43% | Upgrade
|
| Free Cash Flow | 89.88 | 34.18 | 49.99 | -1.11 | 47.73 | 12.02 | Upgrade
|
| Free Cash Flow Per Share | 0.08 | 0.03 | 0.05 | -0.00 | 0.04 | 0.01 | Upgrade
|
| Dividend Per Share | 0.031 | 0.031 | 0.031 | 0.030 | 0.024 | 0.022 | Upgrade
|
| Dividend Growth | - | - | 3.33% | 25.00% | 9.09% | 4.76% | Upgrade
|
| Gross Margin | 84.04% | 83.56% | 82.17% | 83.50% | 83.08% | 81.69% | Upgrade
|
| Operating Margin | 29.43% | 27.28% | 27.56% | 27.84% | 28.81% | 29.42% | Upgrade
|
| Profit Margin | 27.66% | 25.94% | 27.48% | 25.60% | 25.25% | 25.07% | Upgrade
|
| Free Cash Flow Margin | 28.19% | 11.92% | 17.83% | -0.40% | 19.97% | 5.55% | Upgrade
|
| EBITDA | 111.25 | 95.26 | 94.21 | 92.61 | 82.59 | 74.62 | Upgrade
|
| EBITDA Margin | 34.89% | 33.22% | 33.61% | 33.44% | 34.55% | 34.48% | Upgrade
|
| D&A For EBITDA | 17.4 | 17.03 | 16.96 | 15.5 | 13.73 | 10.95 | Upgrade
|
| EBIT | 93.84 | 78.23 | 77.25 | 77.11 | 68.87 | 63.67 | Upgrade
|
| EBIT Margin | 29.43% | 27.28% | 27.56% | 27.84% | 28.81% | 29.42% | Upgrade
|
| Effective Tax Rate | 12.57% | 11.98% | 8.00% | 12.32% | 13.23% | 16.32% | Upgrade
|
| Advertising Expenses | - | 56.68 | 56.87 | 57.89 | 48.38 | 42.18 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.